デフォルト表紙
市場調査レポート
商品コード
1310084

医薬品スクリーニング市場:製品・サービス、サンプルタイプ、エンドユーザー別-2023-2030年の世界予測

Drug Screening Market by Product & Service, Sample Type, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
医薬品スクリーニング市場:製品・サービス、サンプルタイプ、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品スクリーニングの世界市場は、2023年に84億2,304万米ドル、CAGR14.41%で大きく成長し、2030年には217億802万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の医薬品スクリーニング市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.医薬品スクリーニングの世界市場規模および予測は?

2.予測期間中、世界の医薬品スクリーニング市場を形成するCOVID-19の阻害要因と影響は?

3.医薬品スクリーニングの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.医薬品スクリーニングの世界市場における競争戦略は?

5.医薬品スクリーニングの世界市場における技術動向と規制の枠組みは?

6.医薬品スクリーニングの世界市場における主要ベンダーの市場シェアは?

7.医薬品スクリーニングの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 創薬プロジェクトの重要性が高まる
      • 慢性疾患の有病率と高齢者人口の増加
      • 市場関係者間の市場での競合の激化
    • 抑制要因
      • 医薬品スクリーニングの結果が操作される可能性
    • 機会
      • 革新的な医薬品スクリーニングテクノロジーとキットの開発
      • 医薬品スクリーニングの精度を向上させるための技術の進歩
      • 新興国における大きな成長機会
    • 課題
      • 医薬品スクリーニング機器の品質と安全性を評価するために定められた厳しい政府規制
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 医薬品スクリーニング市場製品&サービス別

  • 医薬品スクリーニング製品
    • 分析機器
      • 飲酒検知器
      • 燃料電池アルコール検知器
      • 半導体飲酒検知装置
      • クロマトグラフィー機器
      • 免疫測定分析装置
    • アッセイキット
    • キャリブレーターとコントロール
    • 消耗品
    • 迅速検査装置
      • 口腔液検査装置
      • 尿検査装置
      • ディップカード
      • 薬物検査カセット
      • 薬物検査カップ
    • サンプル採取チューブ
  • 医薬品スクリーニングサービス

第7章 医薬品スクリーニング市場サンプルタイプ別

  • 呼気サンプル
  • 毛髪サンプル
  • 口腔液サンプル
  • 尿サンプル

第8章 医薬品スクリーニング市場:エンドユーザー別

  • 刑事司法制度と法執行機関
  • 薬物検査研究所
  • 薬物治療センター
  • 病院
  • 個人ユーザー
  • 疼痛管理センター
  • 学校と大学
  • 職場

第9章 南北アメリカの医薬品スクリーニング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の医薬品スクリーニング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの医薬品スクリーニング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. DRUG SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG SCREENING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
  • FIGURE 5. DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG SCREENING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. DRUG SCREENING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG SCREENING MARKET DYNAMICS
  • FIGURE 9. DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG SCREENING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 22. DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. DRUG SCREENING MARKET SIZE, BY DRUG SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY DRUG SCREENING MARKET SIZE, BY PRODUCT & S
目次
Product Code: MRR-DD6333AE5BAF

The Global Drug Screening Market is forecasted to grow significantly, with a projected USD 8,423.04 million in 2023 at a CAGR of 14.41% and expected to reach a staggering USD 21,708.02 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Screening Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Screening Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product & Service, market is studied across Drug Screening Products and Drug Screening Services. The Drug Screening Products is further studied across Analytical Instruments, Assay Kits, Calibrators & Controls, Consumables, Rapid Testing Devices, and Sample Collection Tubes. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Breathalyzers is further studied across Fuel-Cell Breathalyzers and Semiconductor Breathalyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices. The Urine Testing Devices is further studied across Dip Cards, Drug Testing Cassettes, and Drug Testing Cups. The Drug Screening Services is projected to witness significant market share during forecast period.

Based on Sample Type, market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples. The Breath Samples is projected to witness significant market share during forecast period.

Based on End User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Schools & Colleges, and Workplaces. The Drug Treatment Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Screening Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Screening Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Screening Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Screening Market?

4. What is the competitive strategic window for opportunities in the Global Drug Screening Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Screening Market?

6. What is the market share of the leading vendors in the Global Drug Screening Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Screening Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Screening Market, by Product & Service, 2022 vs 2030
  • 4.3. Drug Screening Market, by Sample Type, 2022 vs 2030
  • 4.4. Drug Screening Market, by End User, 2022 vs 2030
  • 4.5. Drug Screening Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing importance given to drug discovery projects
      • 5.1.1.2. Higher prevalence of chronic disorders and geriatric population
      • 5.1.1.3. Increasing competition in the market among market players
    • 5.1.2. Restraints
      • 5.1.2.1. Possibility of manipulation of drug screening results
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of innovative drug screening technologies and kits
      • 5.1.3.2. Technological advancements to improve the accuracy of drug screening
      • 5.1.3.3. Significant growth opportunities in the emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations laid down to assess the quality and safety of drug screening equipment
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Screening Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Drug Screening Products
    • 6.2.1. Analytical Instruments
      • 6.2.1.1. Breathalyzers
      • 6.2.1.1.1. Fuel-Cell Breathalyzers
      • 6.2.1.1.2. Semiconductor Breathalyzers
      • 6.2.1.2. Chromatography Instruments
      • 6.2.1.3. Immunoassay Analyzers
    • 6.2.2. Assay Kits
    • 6.2.3. Calibrators & Controls
    • 6.2.4. Consumables
    • 6.2.5. Rapid Testing Devices
      • 6.2.5.1. Oral Fluid Testing Devices
      • 6.2.5.2. Urine Testing Devices
      • 6.2.5.2.1. Dip Cards
      • 6.2.5.2.2. Drug Testing Cassettes
      • 6.2.5.2.3. Drug Testing Cups
    • 6.2.6. Sample Collection Tubes
  • 6.3. Drug Screening Services

7. Drug Screening Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Breath Samples
  • 7.3. Hair Samples
  • 7.4. Oral Fluid Samples
  • 7.5. Urine Samples

8. Drug Screening Market, by End User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Drug Testing Laboratories
  • 8.4. Drug Treatment Centers
  • 8.5. Hospitals
  • 8.6. Individual Users
  • 8.7. Pain Management Centers
  • 8.8. Schools & Colleges
  • 8.9. Workplaces

9. Americas Drug Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing